Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Follicular Dendritic Cell Sarcoma Presenting as a Peripancreatic Mass: Morphologic Findings and Review of the Immunophenotypic Spectrum.

Created on 17 Nov 2026

Authors

Juan Luis Gomez Marti, Saeed Asiry, Gvantsa Kipiani, Dominck Guerrero, Samer Ali, Alyssa Yurovitsky, Tamara Giorgadze

Published in

International journal of surgical pathology. Pages 10668969261504969. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

Follicular dendritic cell sarcoma (FDCS) is a rare mesenchymal neoplasm derived from follicular dendritic cells. While aspiration-based cytologic assessments and core-needle biopsies (CNBs) on sarcomas may often be the only tool to guide treatment decisions, descriptions of FDCS remain limited, and diagnosis is challenging due to its broad morphologic spectrum and immunophenotypic overlap with other spindle and epithelioid neoplasms. We describe a patient with FDCS initially presenting as a peripancreatic mass within the gastrohepatic ligament, followed by rapid development of diffuse hepatic metastases. Fine-needle aspiration of liver lesions demonstrated characteristic but subtle morphologic features that, in retrospect, correlate with reported patterns of FDCS in cytologic specimens. This report highlights the uncommon presentation and morphologic findings of metastatic FDCS, underscores key diagnostic pitfalls, and expands the limited literature on this rare entity.

PMID:
43043311
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement